The Centers for Medicaid and Medicare Services (CMS) announced a model on February 14, 2023 that would allow CMS to pay less for drugs approved via FDA’s accelerated approval pathway before a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results